Celldex Therapeutics | CLDX - Le Chiffre D'Affaires De Vente





Ventes Changement Date
AbbVie USD 15B 1.62B 2026-03
Agenus USD 34.2M 3.97M 2025-12
Amgen USD 8.62B 1.28B 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Celldex Therapeutics USD 121K 769K 2025-12
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Northwest Biotherapeutics USD 200K 245K 2025-09
Pfizer USD 14.5B 3.08B 2026-03
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Roche Holding CHF 15.65B 274.5M 2025-12